Online article for Non-subscribers

Pay per view

Heterocycles has a pay-per-view service for Non-subscribers.
You will be able to directly purchase the full text article through PayPal.
Your purchased Paper can be downloaded after the payment is completed.
An e-mail will be sent the URL to download the paper.
If you have any questions, please contact:

Price: ¥ 4,400 (Yen only)
Period: This Article can be accessed for 7 days.

Short Paper | Regular issue | Vol 104, No. 10, 2022, pp.1845-1853
Published online, 17th August, 2022
DOI: 10.3987/COM-22-14706
Antiviral Activity of Some C3-Symmetrical N-Methyl Benzylamine-Substituted 1,3,5-Triazines and Related Compounds

Shunsuke Shimomura, Kazumi Yokomizo, Jian-Rong Zhou, Nobuko Mibu, Makoto Furutachi, and Kunihiro Sumoto*

*Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan


We report a few new C3-symmetrical 1,3,5-triazine (TAZ) derivatives and the results of evaluation of their anti-herpes simplex virus type 1 (anti-HSV-1) activity and cytotoxic activity against Vero cells. Among the tested TAZ derivatives 3a~3f, a new C3-symmetrical trisubstituted TAZ molecule (3d-Me) showed a considerably high level of anti-HSV-1 activity (EC50 = 4.2 μM) with low cytotoxicity (CC50 => 200 μM) against Vero cells, but its activity was lower than that of original N-demethylated compound 3d-H (A). The results for N-methylated C3-symmetrical multivalent molecules (3c-Me~3e-Me) seem to provide interesting information for a derivatization in the search for new C3-type symmetrical antiviral TAZ derivatives.